The Wall Street Journal @WSJ
🎧 Listen: In part 4 of our series "Uncontrolled Substances," @RolfeWinkler and @khadeeja_safdar explain how distrust of telehealth startup Cerebral started to spread from patients to pharmacies to employees—and eventually to federal investigators https://t.co/OdTJcgJ7nZ — PolitiTweet.org